Biomea Fusion To Participate In Upcoming Investor Events
REDWOOD CITY, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a biopharmaceutical company focused on the......
Agios to Participate in March Investor Conferences
CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism pioneering......
German American Bank announces Michael F. Beckwith as Chief
JASPER, Ind., March 02, 2023 (GLOBE NEWSWIRE) -- German American Bancorp, Inc. (NASDAQ: GABC) and its banking subsidiary, German American Bank, announces......
Aerovate Therapeutics to Present at Cowen 43rd Annual
WALTHAM, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on......
Homology Medicines to Participate in the 43rd Annual Cowen
BEDFORD, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Albert......
Medicenna to Present at the Oppenheimer 33rd Annual
TORONTO and HOUSTON, March 02, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a......
Pharvaris to Present in Upcoming March Investor
ZUG, Switzerland, March 02, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor......
Lands' End Announces Fourth Quarter and Fiscal 2022
DODGEVILLE, Wis., March 02, 2023 (GLOBE NEWSWIRE) -- Lands' End, Inc. (NASDAQ: LE) will host a conference call at 8:30 a.m. Eastern Time on Thursday,......
Cerevel Therapeutics to Present at the 43rd Annual Cowen
CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain......
Great Elm Capital Corp. Announces Fourth Quarter and Full
Company to Host Conference Call and Webcast at 8:30 AM ET Today......